These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 18503889

  • 21. 4-(Azolylphenyl)-phthalazin-1-amines: Novel inhibitors of VEGF receptors I and II.
    Kiselyov AS, Semenov VV, Milligan D.
    Chem Biol Drug Des; 2006 Dec; 68(6):308-13. PubMed ID: 17177892
    [Abstract] [Full Text] [Related]

  • 22. Parathyroid hormone-related protein interacts with vascular endothelial growth factor to promote fibrogenesis in the obstructed mouse kidney.
    Ardura JA, Berruguete R, Rámila D, Alvarez-Arroyo MV, Esbrit P.
    Am J Physiol Renal Physiol; 2008 Aug; 295(2):F415-25. PubMed ID: 18550647
    [Abstract] [Full Text] [Related]

  • 23. Autocrine and paracrine roles of VEGF/VEGFR-2 and VEGF-C/VEGFR-3 signaling in angiosarcomas of the scalp and face.
    Tokuyama W, Mikami T, Masuzawa M, Okayasu I.
    Hum Pathol; 2010 Mar; 41(3):407-14. PubMed ID: 19913279
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Vascular endothelial growth factor expression and vascularity in renal allograft biopsies.
    Sarioğlu S, Celik A, Erşen A, Uçer I, Sağlam F, Camsari T, Gülay H.
    Transplant Proc; 2008 Mar; 40(1):178-80. PubMed ID: 18261579
    [Abstract] [Full Text] [Related]

  • 26. Involvement of the vascular endothelial growth factor receptor-1 in murine hepatocellular carcinoma development.
    Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Yanase K, Namisaki T, Kitade M, Yamazaki M, Tsujinoue H, Masaki T, Fukui H.
    J Hepatol; 2004 Jul; 41(1):97-103. PubMed ID: 15246214
    [Abstract] [Full Text] [Related]

  • 27. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
    Zhang W, Liu M, Wu Y, Zhu P, Yin C, Zhang W, Gu M.
    J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
    [Abstract] [Full Text] [Related]

  • 28. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
    Dardik R, Inbal A.
    Exp Cell Res; 2006 Oct 01; 312(16):2973-82. PubMed ID: 16914140
    [Abstract] [Full Text] [Related]

  • 29. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity.
    Kitagawa Y, Dai J, Zhang J, Keller JM, Nor J, Yao Z, Keller ET.
    Cancer Res; 2005 Dec 01; 65(23):10921-9. PubMed ID: 16322239
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S, Bezdekova M, Brychta T, Tichy M.
    Neoplasma; 2008 Dec 01; 55(4):273-9. PubMed ID: 18505336
    [Abstract] [Full Text] [Related]

  • 32. Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejection.
    Reinders ME, Fang JC, Wong W, Ganz P, Briscoe DM.
    Transplantation; 2003 Jul 15; 76(1):224-30. PubMed ID: 12865814
    [Abstract] [Full Text] [Related]

  • 33. Early short-term platelet-derived growth factor inhibition prevents the development of chronic allograft nephropathy in experimental rat kidney transplantation.
    Savikko J, Rintala J, von Willebrand E.
    Transplant Proc; 2006 Dec 15; 38(10):3231-2. PubMed ID: 17175231
    [Abstract] [Full Text] [Related]

  • 34. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension.
    Xia L, Fu GS, Yang JX, Zhang FR, Wang XX.
    Cytotherapy; 2009 Dec 15; 11(4):492-502. PubMed ID: 19526390
    [Abstract] [Full Text] [Related]

  • 35. VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma.
    Rivet J, Mourah S, Murata H, Mounier N, Pisonero H, Mongiat-Artus P, Teillac P, Calvo F, Janin A, Dosquet C.
    Cancer; 2008 Jan 15; 112(2):433-42. PubMed ID: 18041056
    [Abstract] [Full Text] [Related]

  • 36. Microvessel density and VEGF/VEGF receptor status and their role in sarcomas of the pulmonary artery.
    Gaumann AK, Schermutzki G, Mentzel T, Kirkpatrick CJ, Kriegsmann JB, Konerding MA.
    Oncol Rep; 2008 Feb 15; 19(2):309-18. PubMed ID: 18202776
    [Abstract] [Full Text] [Related]

  • 37. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes.
    Tchaikovski V, Olieslagers S, Böhmer FD, Waltenberger J.
    Circulation; 2009 Jul 14; 120(2):150-9. PubMed ID: 19564559
    [Abstract] [Full Text] [Related]

  • 38. [Vascular endothelial growth factor and two types of its receptors in breast cancer].
    Shcherbakov AM, Gershteĭn ES, Anurova OA, Kushlinskiĭ NE.
    Vopr Onkol; 2005 Jul 14; 51(3):317-21. PubMed ID: 16279095
    [Abstract] [Full Text] [Related]

  • 39. Vatalanib decrease the positive interaction of VEGF receptor-2 and P2X2/3 receptor in chronic constriction injury rats.
    Liu S, Xu C, Li G, Liu H, Xie J, Tu G, Peng H, Qiu S, Liang S.
    Neurochem Int; 2012 May 14; 60(6):565-72. PubMed ID: 22361062
    [Abstract] [Full Text] [Related]

  • 40. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats.
    Liu M, Gu M, Wu Y, Zhu P, Zhang W, Yin C, Zhang WJ.
    J Surg Res; 2009 Nov 14; 157(1):e117-27. PubMed ID: 19589538
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.